CMFRI develops seaweed neutraceutical that helps in post-Covid complications The Pioneer dated 25th July 2023

CMFRI, Library (2023) CMFRI develops seaweed neutraceutical that helps in post-Covid complications The Pioneer dated 25th July 2023. The Pioneer.

[img] Text
The Pioneer_25-07-2023.pdf

Download (89kB)

Abstract

The Central Marine Research Institute has developed a nutraceutical product from select seaweeds that boosts innate immunity against post-Covid complications. Named as ‘CadalminTM Immunalgin’ extract (CadalminTM IMe), the product also has antiviral properties against the delta variant of SARS CoV-2 virus, the ICAR-Central Marine Fisheries Research Institute (CMFRI) said in a statement here on July 24.

Item Type: Article
Subjects: CMFRI News Clippings
Divisions: Library and Documentation Centre
Depositing User: Mr. Augustine Sipson N A
Date Deposited: 02 Aug 2023 07:35
Last Modified: 02 Aug 2023 07:35
URI: http://eprints.cmfri.org.in/id/eprint/17290

Actions (login required)

View Item View Item